Gene · 9965
Papers4,178
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 4,178
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Statement of Retraction: Forkhead-box C1 attenuates high glucose-induced trophoblast cell injury during gestational diabetes mellitus via activating adenosine monophosphate-activated protein kinase through regulating fibroblast growth factor 19. | Bioengineered | 2024 | 38376880 | PubTator, text mining | PubMed |
| Discovery of 6-Formylpyridyl Urea Derivatives as Potent Reversible-Covalent Fibroblast Growth Factor Receptor 4 Inhibitors with Improved Anti-Hepatocellular Carcinoma Activity. | J Med Chem | 2024 | 38348819 | PubTator, text mining | PubMed |
| Bile Acid Diarrhea: From Molecular Mechanisms to Clinical Diagnosis and Treatment in the Era of Precision Medicine. | Int J Mol Sci | 2024 | 38338820 | PubTator, text mining | PubMed |
| FXR-FGF19 signaling in the gut-liver axis is dysregulated in patients with cirrhosis and correlates with impaired intestinal defence. | Hepatol Int | 2024 | 38332428 | PubTator, text mining | PubMed |
| A genome-wide association study for survival from a multi-centre European study identified variants associated with COVID-19 risk of death. | Sci Rep | 2024 | 38321133 | PubTator, text mining | PubMed |
| R-Spondin 2 governs Xenopus left-right body axis formation by establishing an FGF signaling gradient. | Nat Commun | 2024 | 38307837 | PubTator, text mining | PubMed |
| From MASH to HCC: the role of Gas6/TAM receptors. | Front Immunol | 2024 | 38298195 | PubTator, text mining | PubMed |
| Association of metabolic-dysfunction associated steatotic liver disease with polycystic ovary syndrome. | iScience | 2024 | 38292434 | PubTator, text mining | PubMed |
| Fibroblast growth factor 21: An emerging pleiotropic regulator of lipid metabolism and the metabolic network. | Genes Dis | 2024 | 38292170 | PubTator, text mining | PubMed |
| Crohn's Disease-Associated Pathogenic Mutation in the Manganese Transporter ZIP8 Shifts the Ileal and Rectal Mucosal Microbiota Implicating Aberrant Bile Acid Metabolism. | Inflamm Bowel Dis | 2024 | 38289995 | PubTator, text mining | PubMed |
| Optimal drug regimens for improving ALP biochemical levels in patients with primary biliary cholangitis refractory to UDCA: a systematic review and Bayesian network meta-analysis. | Syst Rev | 2024 | 38287391 | PubTator, text mining | PubMed |
| Prognostic DNA mutation and mRNA expression analysis of perineural invasion in oral squamous cell carcinoma. | Sci Rep | 2024 | 38287071 | PubTator, text mining | PubMed |
| Gut microbiota and metabolite interface-mediated hepatic inflammation. | Immunometabolism (Cobham) | 2024 | 38283696 | PubTator, text mining | PubMed |
| Sarcopenia and frailty in inflammatory bowel disease: Emerging concepts and evidence. | JGH Open | 2024 | 38283070 | PubTator, text mining | PubMed |
| Recent Progress in Systemic Therapy for Advanced Hepatocellular Carcinoma. | Int J Mol Sci | 2024 | 38279258 | PubTator, text mining | PubMed |
| New Therapeutic Approaches for the Treatment of Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Increased Cardiovascular Risk. | Diagnostics (Basel) | 2024 | 38275476 | PubTator, text mining | PubMed |
| The anti-tumor effects of AZD4547 on ovarian cancer cells: differential responses based on c-Met and FGF19/FGFR4 expression. | Cancer Cell Int | 2024 | 38273381 | PubTator, text mining | PubMed |
| Molecular Targeting of the Fibroblast Growth Factor Receptor Pathway across Various Cancers. | Int J Mol Sci | 2024 | 38255923 | PubTator, text mining | PubMed |
| Bile Acid Metabolic Profiles and Their Correlation with Intestinal Epithelial Cell Proliferation and Barrier Integrity in Suckling Piglets. | Animals (Basel) | 2024 | 38254456 | PubTator, text mining | PubMed |
| Nasopharyngeal carcinoma: current views on the tumor microenvironment's impact on drug resistance and clinical outcomes. | Mol Cancer | 2024 | 38254110 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9965/papers?page=18